Spend $99, get free U.S. shipping*

Tariff now required on U.S. shipments. Learn more »

Tel: 1-866-456-3768 Fax: 1-866-544-8993

Due to the current situation in Israel some orders may be delayed

For visual reference only; actual product may vary

  • US Name:

    Uptravi

  • Alternative Names:

    Uptravi

  • Active Ingredients:

    Selexipag

  • Brand Manufacturer:

    Johnson & Johnson

  • Manufacturer Location:

  • Click here to view Product Insert

  • Click here to view Product Insert

Uptravi *

For visual reference only; actual product may vary

Prescription Required
All third-party products, company names, and logos are trademarks™ or registered® trademarks are and remain the property of their respective holders. Their use does not imply any affiliation with or endorsement by them. All references on this site to third-party trademarks are intended to constitute nominative fair use under applicable trademark laws.

Uptravi is prescribed for the treatment of pulmonary arterial hypertension (PAH, WHO Group I).

Place your order

Uptravi Brand 1600mcg
60 Tablets
-
+
Our price:
$3,800.00
Uptravi Brand 1400mcg
60 Tablets
-
+
Our price:
$3,800.00
Uptravi Brand 1200mcg
60 Tablets
-
+
Our price:
$3,800.00
Uptravi Brand 1000mcg
60 Tablets
-
+
Our price:
$3,800.00
Uptravi Brand 800mcg
60 Tablets
-
+
Our price:
$3,800.00
Uptravi Brand 600mcg
60 Tablets
-
+
Our price:
$3,800.00
Uptravi Brand 400mcg
60 Tablets
-
+
Our price:
$3,800.00
Uptravi Brand 200mcg
60 Tablets
-
+
Our price:
$3,700.00

*Please note all prices are in US dollars

Uptravi (generic name: selexipag) is prescribed for the treatment of pulmonary arterial hypertension (PAH, WHO Group I), a condition characterized by high pulmonary artery pressure that strains the heart and lungs.

Selexipag is a prostacyclin receptor agonist that will selectively stimulate the prostacyclin IP receptor on vascular smooth muscle cells, promoting vasodilation, inhibiting vascular remodeling, and reducing platelet aggregation. This helps to slow disease progression and reduce the risk of hospitalization,

Dosage

Follow the instructions on the label of the Uptravi box. If you have any questions, consult with a doctor or pharmacist.

The typical oral dosing regimen begins at 200 mcg twice daily, with food, approximately 12 hours apart. Typically, the dose is gradually increased weekly in 200 mcg increments until the highest tolerated dose is reached, up to a maximum of 1600 mcg twice daily.

If a patient misses a dose and the next scheduled dose is more than 6 hours away, take it as soon as remembered. If less than 6 hours remain, skip the missed dose and continue with your normal schedule. Don’t stop taking the medicine without consulting a doctor. In the event of an accidental overdose,  call 911 or go to an emergency medical care center immediately.

Storage

Tablets should be stored at 20–25 °C (68–77 °F) in original packaging, protected from moisture and out of children’s reach. If in any doubt, consult our blog on safe medicine management.

This text is for informational purposes only. Please consult a doctor or pharmacist before using any medication. 

Read the information leaflet that comes with the medication.

If a sudden allergic reaction (anaphylaxis) occurs shortly after taking Uptravi, with symptoms like swelling of the face, tongue, or throat making it difficult to breathe or swallow, or there is wheezing, hives, rash, blistering, or peeling of the skin, call a doctor or 911 right away, or go to an emergency room immediately.

Most people who use Uptravi do not experience any adverse side effects. Doctors prescribe this medication because they assess the benefits of such treatment outweigh any likely unwanted effects.

Some of the side effects that have been reported include:

  • headache
  • diarrhea
  • jaw pain
  • nausea and vomiting
  • myalgia
  • pain in arms or legs
  • flushing
  • joint pain
  • anemia
  • rash
  • decreased appetite
  • upper respiratory symptoms.

Not all side effects are listed here. If these or other unlisted symptoms persist or worsen, consult a healthcare provider or pharmacist.

Uptravi is approved for adult patients with pulmonary arterial hypertension (PAH, WHO Group I), a chronic condition marked by constriction and remodeling of pulmonary arteries, leading to elevated blood pressure within these vessels.

PAH symptoms include shortness of breath, fatigue, dizziness, chest pain, swelling of ankles or legs, and reduced ability to perform exercise due to impaired blood flow to the lungs and heart.

Getting started with IsraelPharm

Required

Send Your Prescription

Secure Payment

No Hidden Fees

Fast Shipping

Generally 7-10 Business Days

Fast delivery
Secure payment
Genuine brands
Pharmacist oversight
Proudly Israeli

Ordering is
simple and safe.

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.

Read more from our blog

prescription compliance

Do Longer Prescriptions Improve Compliance

Multiple studies have shown that prescription compliance improves when the doctor chooses 90-day vs 30-day prescriptions, since the script covers longer periods, making acquisition simpler by requiring fewer calls to the pharmacy for refills for

Read More »
tear evaporation and dry eyes

Why Modern Life is Drying Out Our Tears

Tears play an important part in eye health and general comfort, but because they’re “invisible”, people don’t appreciate just how much we depend on them until something goes wrong with the flow. Dry eyes can

Read More »

Login

Fast Delivery
Ships from Israel
Secure Payment
Genuine Brands
Pharmacist Oversight
Proudly Israeli
Free Shipping on orders over $99*

Having issues?

Daily from 9am-8pm EST.
IsraelPharm c/o SUBS Ltd. Ha'Uman 5 Bet Shemesh Israel, 9906105

Sign up for $10 off your first order!

Enjoy exclusive deals we only share via email